Skip to main content
Fig. 4 | BMC Cancer

Fig. 4

From: Improving anticancer effect of aPD-L1 through lowering neutrophil infiltration by PLAG in tumor implanted with MB49 mouse urothelial carcinoma

Fig. 4

TINs were analyzed in tumor tissue from mice treated with PLAG. a Ly6G+ neutrophils in tumor tissue from mice treated with PLAG were counted. Among CD45+ leukocytes, Ly6G+ and CD11b+ cells were sorted by FACS. b Ly6G+ and CD11b+ TINs were analyzed in tumor tissue from mice treated with PLAG. Compared with the tumor only: #P < 0.05, ##P < 0.01, ###P < 0.001; compared with the aPD-L1 only treatment group: $P < 0.05, $$P < 0.01, $$$P < 0.001 (n = 3 for each experiment). N.S, not significant. Mean ± SD. c TINs in tumor tissue from mice treated with PLAG were confirmed by IHC staining with anti-Ly6G and anti-neutrophil elastase. d DAB-positive cells in tumor tissue stained with anti-Ly6G and anti-neutrophil elastase were analyzed. Compared with the tumor only: #P < 0.05, ##P < 0.01, ###P < 0.001; compared with the aPD-L1-only treatment group: $P < 0.05, $$P < 0.01, $$$P < 0.001 (n = 3 for each experiment). N.S, not significant. Mean ± SD

Back to article page